HNGE:NYSE
Hinge Health Inc
$105.14
arrow_upward
+0.31%(+0.32) 1D
$106.25
arrow_upward
+1.05% (+1.11)bedtimeAfter hours
Closed: Oct 13, 4:00:02 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HNGE...
Open
$107.00
High
$107.00
Low
$103.18
Mkt. cap
8.48B
Avg. vol.
1.87M
Volume
879.88K
P/E ratio
80.36
52-wk high
$107.00
52-wk low
$30.08
EPS
$1.31
Shares outstanding
62.47M
No. of employees
1K
Open
$107.00
High
$107.00
Low
$103.18
Mkt. cap
8.48B
Avg. vol.
1.87M
Volume
879.88K
P/E ratio
80.36
52-wk high
$107.00
52-wk low
$30.08
EPS
$1.31
Shares outstanding
62.47M
No. of employees
1K
News stories
From web sources and news partners
MarketBeat
·
3 hours ago
Insider Selling: Hinge Health (NYSE:HNGE) Chairman Sells 200,000 Shares of Stock
MarketBeat
·
3 hours ago
Hinge Health (NYSE:HNGE) CFO James Budge Sells 47,720 Shares of Stock
Investing.com Canada
·
4 hours ago
Hinge Health (HNGE) CFO budge sells $4.9m in common shares
Stock Titan
·
5 hours ago
Under a June 11 trading plan, Hinge Health (HNGE) CFO sells 47,720 shares.
About Hinge Health Inc
CEO-
Employees1.44K
Founded2012
HeadquartersSan Francisco, California, United States
SectorHealth care provider
Websitehingehealth.com
Analyst ratings
Based on 13 analysts giving stock ratings to HNGE in the past 3 months
Strong buy
Buy
12
Hold
1
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for HNGE in the last 3 months.
Highest
Current $105.14
$117.00 (+11.28%)
Average
$106.27 (+1.07%)
Lowest
$90.00 (-14.40%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Craig Hettenbach Morgan Stanley | Buy | Maintained | $117.00 | +11.3% | 10/12/2026 |
Saket Kalia Barclays | Buy | Reiterated | $110.00 | +4.6% | 10/12/2026 |
Tomer Zilberman Bank of America Securities | Buy | Initiated | $110.00 | +4.6% | 09/29/2026 |
Terry Tillman Truist Financial | Buy | Maintained | - | - | 09/28/2026 |
Vikram Kesavabhotla Robert W. Baird | Hold | Maintained | $90.00 | -14.4% | 09/22/2026 |
David Grossman Stifel Nicolaus | Buy | Maintained | $115.00 | +9.4% | 09/08/2026 |
Jailendra Singh Truist Financial | Buy | Reiterated | $112.00 | +6.5% | 08/11/2026 |
Eugene Mannheimer Freedom Capital Markets | Buy | Reiterated | $103.00 | -2% | 08/10/2026 |
Rishi Jaluria RBC Capital | Buy | Maintained | $110.00 | +4.6% | 08/04/2026 |
Richard Close Canaccord Genuity | Buy | Reiterated | $105.00 | -0.1% | 08/05/2026 |
Aaron Kimson Citizens JMP | Buy | Maintained | $107.00 | +1.8% | 08/05/2026 |
Ryan MacDonald Needham | Buy | Reiterated | $97.00 | -7.7% | 08/05/2026 |
Ryan Daniels William Blair | Buy | Maintained | - | - | 08/04/2026 |
Elizabeth Anderson CFA Evercore ISI | Buy | Maintained | $105.00 | -0.1% | 08/04/2026 |
Scott Schoenhaus KeyBanc | Buy | Maintained | $125.00 | +18.9% | 07/13/2026 |
Stan Berenshteyn Wells Fargo | Buy | Reiterated | $90.00 | -14.4% | 06/24/2026 |
Brian Peterson Raymond James | Buy | Maintained | $80.00 | -23.9% | 06/15/2026 |
Jessica Tassan Piper Sandler | Buy | Maintained | $95.00 | -9.6% | 05/06/2026 |
Kenneth Herbert RBC Capital | Buy | Maintained | $55.00 | -47.7% | 03/10/2026 |
Bradley Sills Bank of America Securities | Buy | Maintained | $64.00 | -39.1% | 02/10/2026 |
Last report
Aug 4, 2026
Fiscal period
Q2 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$0.59 / $0.62
-4.07%miss
arrow_downward
Revenue / Est. (USD)
212.82M / 201.49M
+5.62%beat
arrow_upward
Fiscal Q2 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 154.21M | 170.73M | 182.31M | 212.82M |
Cost of goods sold | 27.97M | 26.55M | 27.97M | 28.82M |
Cost of revenue | 27.97M | 26.55M | 27.97M | 28.82M |
Research and development expenses | 31.92M | 32.76M | 29.64M | 34.06M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 100.37M | 84.02M | 91.13M | 109.45M |
Operating expense | 132.33M | 116.92M | 122.27M | 143.55M |
Total operating expenses | 160.30M | 143.47M | 150.24M | 172.38M |
Operating income | -6.09M | 27.26M | 32.07M | 40.44M |
Other non operating income | -5.00K | 166.00K | -77.00K | 115.00K |
EBT including unusual items | -1.64M | 32.22M | 35.94M | 44.43M |
EBT excluding unusual items | -1.64M | 32.22M | 35.94M | 44.43M |
Income tax expense | 206.00K | 122.00K | 814.00K | 740.00K |
Effective tax rate | -12.58% | 0.38% | 2.26% | 1.67% |
Other operating expenses | 40.00K | 147.00K | 1.50M | 45.00K |
Net income | -1.84M | 32.10M | 35.13M | 43.69M |
Net profit margin | -1.20% | 18.80% | 19.27% | 20.53% |
Earnings per share | 0.44 | 0.49 | 0.45 | 0.59 |
Interest and investment income | 4.46M | 4.80M | 3.95M | 3.88M |
Interest expense | - | - | - | - |
Net interest expenses | 4.46M | 4.80M | 3.95M | 3.88M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -5.53M | 27.78M | 32.54M | 40.90M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1